Cardiovascular risk factors in patients with ulcerative colitis

Cover Page

Cite item

Full Text

Abstract

Background. Given the current trends in increasing the life expectancy of patients with ulcerative colitis (UC), the study of the risk of atherothrombotic events in them requires study. For effective prevention of cardiovascular diseases, it is necessary to assess cardiovascular risk factors since the concept of their timely detection is the basic one when planning preventive measures.

Aim. To assess the prevalence of cardiovascular risk factors in patients with UC.

Materials and methods. One hundred eighty four UC patients participated in the case-control study; 56 participants were included in the control group. The studied parameters are unmodified, behavioral, and biological factors of cardiovascular risk. The study participants were surveyed, examined, measured blood pressure, height, weight, the level of total cholesterol was studied, and the lipid spectrum was analyzed in 80 patients with UC. Parametric and nonparametric statistical methods were used.

Results. UC patients consumed fruit less often, drank tea and coffee with sugar more often, exercised less often and experienced high levels of stress. A higher incidence of arterial hypertension in UC patients was established, even though the fact of taking glucocorticosteroids was considered. No significant differences were found in the assessment of relative and total cardiovascular risk.

Conclusion. Risk management of cardiovascular diseases in UC patients should focus on a personalized approach and timely screening of modifiable cardiovascular risk factors with their subsequent correction. The absence of significant differences in the level of relative and total cardiovascular risk indicates a limited contribution of traditional risk factors to the development of cardiovascular diseases in UC patients.

About the authors

Galiya R. Bicbavova

Omsk State Medical University

Author for correspondence.
Email: galiya1976@mail.ru
ORCID iD: 0000-0001-9252-9152

канд. мед. наук, доц., доц. каф. госпитальной терапии, эндокринологии ФГБОУ ВО ОмГМУ

Russian Federation, Omsk

Oksana M. Drapkina

National Medical Research Center for Preventive Medicine,

Email: galiya1976@mail.ru
ORCID iD: 0000-0002-4453-8430

акад. РАН, д-р мед. наук, проф., дир. ФГБОУ «НМИЦ профилактической медицины»

Russian Federation, Moscow

Maria A. Livzan

Omsk State Medical University

Email: galiya1976@mail.ru
ORCID iD: 0000-0002-6581-7017

чл.-кор. РАН, д-р мед. наук, проф., ректор, зав. каф. факультетской терапии и гастроэнтерологии ФГБОУ ВО ОмГМУ

Russian Federation, Omsk

Natalia S. Lisyutenko

Omsk State Medical University

Email: galiya1976@mail.ru
ORCID iD: 0000-0003-4088-240X

канд. мед наук, ассистент каф. госпитальной терапии, эндокринологии ФГБОУ ВО ОмГМУ

Russian Federation, Omsk

Alisa E. Romanyuk

Omsk State Medical University

Email: galiya1976@mail.ru
ORCID iD: 0000-0001-6308-4377

студентка лечебного фак-та ФГБОУ ВО ОмГМУ

Russian Federation, Omsk

References

  1. Министерство здравоохранения Российской Федерации. Язвенный колит. Клинические рекомендации. 2022. Режим доступа: https://cr.minzdrav.gov.ru/schema/193_1#doc_b. Ссылка активна на 11.06.2023 [Ministry of Health of the Russian Federation. Ulcerative colitis. Clinical guidelines. 2022. Available at: https://cr.minzdrav.gov.ru/schema/193_1#doc_b. Accessed: 11.06.2023 (in Russian)].
  2. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769-78. doi: 10.1016/S0140-6736(17)32448-0
  3. Белоусова Е.А., Абдулганиева Д.И., Алексеева О.П., и др. Социально-демографическая характеристика, особенности течения и варианты лечения воспалительных заболеваний кишечника в России. Результаты двух многоцентровых исследований. Альманах клинической медицины. 2018;46(5):445-63 [Belousova EA, Abdulganieva DI, Alekseeva OP, et al. Social and demographic characteristics, features of disease course and treatment options of inflammatory bowel disease in Russia: results of two multicenter studies. Al'manakh klinicheskoi meditsiny. 2018;46(5):445-63 (in Russian)]. doi: 10.18786/2072-0505-2018-46-5-445-463
  4. Князев О.В., Шкурко Т.В., Каграманова А.В., и др. Эпидемиология воспалительных заболеваний кишечника. Современное состояние проблемы (обзор литературы). Доказательная гастроэнтерология. 2020;9(2):66-73 [Kniazev OV, Shkurko TV, Kagramanova AV, et al. Epidemiology of inflammatory bowel disease. State of the problem (review). Russian Journal of Evidence-Based Gastroenterology. 2020;9(2):66-73 (in Russian)]. doi: 10.17116/DOKGASTRO2020902166
  5. Kuenzig ME, Manuel DG, Donelle J, Benchimol EI. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease. CMAJ. 2020;192(45):E1394-402. doi: 10.1503/cmaj.190976
  6. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77. doi: 10.1093/eurheartj/ehz425
  7. Bergmark BA, Mathenge N, Merlini PA, et al. Acute coronary syndromes. Lancet. 2022;399(10332):1347-58. doi: 10.1016/S0140-6736(21)02391-6
  8. Aniwan S, Pardi DS, Tremaine WJ, Loftus EV Jr. Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16(10):1607-15.e1. doi: 10.1016/j.cgh.2018.04.031
  9. Panhwar MS, Mansoor E, Al-Kindi SG, et al. Risk of myocardial infarction in inflammatory bowel disease: a population-based national study. Inflam Bowel Dis. 2019;25(6):1080-7. doi: 10.1093/ibd/izy354
  10. Rungoe C, Basit S, Ranthe MF, et al. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut. 2013;62(5):689-94. doi: 10.1136/gutjnl-2012-30328
  11. Theocharidou E, Gossios TD, Griva T, et al. Is There an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data. Angiology. 2014;65(6):543-50. doi: 10.1177/0003319713489876
  12. Kappelman MD, Horvath-Puho E, Sandler RS, et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60(7):937-43. doi: 10.1136/gut.2010.228585
  13. Visseren FLJ, Mach F, Smulders YM, et al. 2021 Рекомендации ESC по профилактике сердечно-сосудистых заболеваний в клинической практике. Российский кардиологический журнал. 2022;27(7):191-288 [Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Russian Journal of Cardiology. 2022;27(7):191-288 (in Russian)]. doi: 10.15829/1560-4071-2022-5155
  14. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9
  15. Драпкина О.М., Шальнова С.А., Имаева А.Э., и др. Эпидемиология сердечно-сосудистых заболеваний и их факторов риска в регионах Российской Федерации. Третье исследование (ЭССЕ-РФ-3). Обоснование и дизайн исследования. Кардиоваскулярная терапия и профилактика. 2022;21(5):3246 [Drapkina OM, Shalnova SA, Imaeva AE, et al. Epidemiology of cardiovascular diseases in regions of Russian Federation. Third survey (ESSE-RF-3). Rationale and study design. Cardiovascular Therapy and Prevention. 2022;21(5):3246 (in Russian)]. doi: 10.15829/1728-8800-2022-3246
  16. Jagannathan R, Patel SA, Ali MK, Narayan KMV. Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr Diab Rep. 2019;19(7):44. doi: 10.1007/s11892-019-1161-2
  17. Седых Д.Ю., Петрова Т.С., Хрячкова О.Н., Кашталап В.В. Поведенческие факторы риска у пациентов с инфарктом миокарда и различной профессиональной принадлежностью (исследование в пилотной группе). Атеросклероз. 2023;18(4):338-53 [Sedykh DYu, Petrova TS, Khryachkova ON, Kashtalap VV. Behavioral risk factors in patients with myocardial infarction and different occupations (pilot study). Ateroscleroz. 2022;18(4):338-53 (in Russian)]. doi: 10.52727/2078-256X-2022-18-4-338-353
  18. Ивашкин В.Т., Шелыгин Ю.А., Белоусова Е.А., и др. Проект клинических рекомендаций по диагностике и лечению язвенного колита. Колопроктология. 2019;18(4):7-36 [Ivashkin VT, Shelygin YuA, Belousova EA, et al. Project: clinical guidelines for the diagnostics and treatment of ulcerative colitis. Koloproktologiya. 2019;18(4):7-36 (in Russian)]. doi: 10.33878/2073-7556-2019-18-4-7-36
  19. Шачкуте А. Введение в программу CINDI. Профилактическая медицина. 2017;20(2):5-9 [Shachkute A. Introduction to the CINDI program. Profilakticheskaya meditsina. 2017;20(2):5-9 (in Russian)]. doi: 10.17116/profmed20172025-9
  20. Reeder LG, Chapman JM, Coulson AH. Socioenvironmental stress, tranquilizers and cardiovascular disease. Proceedings of the Excerpta Medica International Congress Series. 1968;182:226-38.
  21. Healthy diet. World Health Organization. 29 April 2020. Available at: https://www.who.int/ru/news-room/fact-sheets/detail/healthy-diet. Accessed: 11.07.2023.
  22. Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161(4):1118-32. doi: 10.1053/j.gastro.2021.07.042
  23. Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Measures of obesity and risk of Crohn's disease and ulcerative colitis. Inflam Bowel Dis. 2015;21(2):361-8. doi: 10.1097/MIB.0000000000000283
  24. Hu Q, Ren J, Li G, et al. The impact of obesity on the clinical course of inflammatory bowel disease: a meta-analysis. Med Sci Monit. 2017;23:2599-606. doi: 10.12659/msm.901969
  25. Kim S, Goel R, Kumar A, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci (Lond). 2018;132(6):701-18. doi: 10.1042/CS20180087
  26. Gurung M, Li Z, You H, et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine. 2020;51:102590. doi: 10.1016/j.ebiom.2019.11.051

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Correlation of total cholesterol with age and duration of UC.

Download (116KB)
3. Fig. 2. Hypertension in UC patients and in the control group.

Download (93KB)

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies